China Pharma Holdings
CPHI
6 hedge funds and large institutions have $998K invested in China Pharma Holdings in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
87% more capital invested
Capital invested by funds: $534K → $998K (+$464K)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
25% less funds holding
Funds holding: 8 → 6 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$215K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$106K |
| 3 |
Morgan Stanley
New York
|
+$431 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$247K |
| 2 |
VF
Virtu Financial
New York
|
-$25K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$15K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$8K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $426K | -$247K | -573 | -36% |
|
|
HF
2
HRT Financial
New York
| $225K | +$215K | +499 | +1,349% |
|
|
BCM
3
Bridgeway Capital Management
Houston,
Texas
| $197K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $113K | +$106K | +245 | +1,021% |
|
|
VF
5
Virtu Financial
New York
| $37K | -$25K | -58 | -39% |
|
|
TSS
6
Two Sigma Securities
New York
| – | -$15K | -69 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$8K | -38 | Closed |
|
|
8
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$6K | -28 | Closed |
|
|
9
Morgan Stanley
New York
| – | +$431 | +1 | New |
|
CPHI Hedge Fund Activity: Q1 2021 in Review
6 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q1 2021, worth a combined $998K — up 87% from $534K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CPHI and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was HRT Financial, adding an estimated $215K. The largest seller was Renaissance Technologies, cutting an estimated $247K.
- 6 institutional investors held China Pharma Holdings (CPHI) as of Q1 2021, down from 8 in Q4 2020.
- Funds reported $998K of China Pharma Holdings stock for Q1 2021, up 87% quarter-over-quarter.
- 1 fund opened new China Pharma Holdings positions in Q1 2021 and 3 closed out, a net change of -2 holders.
- The largest China Pharma Holdings buyer in Q1 2021 was HRT Financial, an estimated $215K added.
- The largest China Pharma Holdings seller in Q1 2021 was Renaissance Technologies, an estimated $247K sold.
Based on aggregated 13F filings for Q1 2021.